MedPath

Novo Nordisk Pharma, Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

3

FDA:3

Drug Approvals

Insulin Aspart Protamine and Insulin Aspart

Approval Date
Feb 28, 2023
FDA

Insulin Aspart

Approval Date
Feb 28, 2023
FDA

Insulin Degludec

Approval Date
Jul 1, 2022
FDA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.